RUNX2, which is included in the gene signature of Fig. 6C, promotes chemotherapy resistance in several types of cancer [48] and inhibits the expression of NR3C1 (encoding for Glucocorticoid Receptor protein) [49]. The gene discussed is NR3C1; the disease is cancer.